# Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs)

> **NCT05198544** · NA · UNKNOWN · sponsor: **SerenaGroup, Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Diabetic Foot

## Interventions

- **DEVICE:** Hēlaquis Matrix is a hyaluronic acid matrix (HaM)

## Key facts

- **NCT ID:** NCT05198544
- **Lead sponsor:** SerenaGroup, Inc.
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05198544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05198544, "Clinical Trial Evaluating a Hyaluronic Acid Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05198544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*